Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPolymyalgia rheumatica and giant cell arteritis
InnovAiT, 09/23/09
Knights G – First described in 1888 by William Bruce, a physician practising in Scotland, polymyalgia rheumatica (PMR) is an inflammatory condition of unknown aetiology. Giant cell arteritis (GCA) is a vasculitis of medium or large arteries, also of unknown cause. Because the two conditions often occur together (5% of patients with PMR develop GCA and conversely 40–50% of patients with GCA also have PMR), they are thought to share the same underlying pathophysiology, being opposite ends of the same spectrum. Unfortunately, there is no firm evidence to support this.
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Effect of biomagnetic therapy versus physiotherapy for treatment of knee osteoarthritis: A randomized controlled trial
Journal of Rehabilitation Medicine, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor